Insider Transactions in Q1 2024 at Marinus Pharmaceuticals, Inc. (MRNS)
Insider Transaction List (Q1 2024)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 27
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+15.46%
|
$200,000
$4.28 P/Share
|
Feb 20
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
SELL
Open market or private sale
|
Direct |
1,894
-3.45%
|
$17,046
$9.57 P/Share
|
Feb 20
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,153
-3.45%
|
$19,377
$9.56 P/Share
|
Feb 16
2024
|
Scott Braunstein CHAIRMAN AND CEO |
SELL
Open market or private sale
|
Direct |
11,850
-5.03%
|
$106,650
$9.94 P/Share
|
Feb 16
2024
|
Steven Pfanstiel CFO AND COO |
SELL
Open market or private sale
|
Direct |
3,092
-4.13%
|
$27,828
$9.97 P/Share
|
Feb 16
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
2,814
-4.05%
|
$25,326
$9.98 P/Share
|
Jan 18
2024
|
Seth H. Z. Fischer |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+30.21%
|
-
|
Jan 18
2024
|
Elan Ezickson |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+31.08%
|
-
|
Jan 18
2024
|
Christine Berni Silverstein |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
Jan 18
2024
|
Marvin Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
Jan 18
2024
|
Sarah B. Noonberg |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+28.05%
|
-
|
Jan 18
2024
|
Steven Pfanstiel CFO AND COO |
BUY
Grant, award, or other acquisition
|
Direct |
25,465
+25.4%
|
-
|
Jan 18
2024
|
Joseph Hulihan CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+23.92%
|
-
|
Jan 18
2024
|
Martha E Manning SVP, GEN. COUNSEL & CORP. SEC. |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+28.47%
|
-
|
Jan 18
2024
|
Christina Shafer CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
21,835
+25.9%
|
-
|
Jan 18
2024
|
Timothy M Mayleben |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+17.24%
|
-
|
Jan 18
2024
|
Charles Austin |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+31.77%
|
-
|
Jan 18
2024
|
Sara Nochur |
BUY
Grant, award, or other acquisition
|
Direct |
4,600
+29.58%
|
-
|
Jan 18
2024
|
Scott Braunstein CHAIRMAN AND CEO |
BUY
Grant, award, or other acquisition
|
Direct |
74,600
+24.07%
|
-
|